SPONSOR
Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea
Total Trials
2
Recruiting
2
Phases
Phase 2
Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea is a clinical research sponsor with 2 registered studies on ClinicalTrials.gov, of which 2 are actively recruiting participants. Research covers conditions including Large B Cell Lymphoma, Hodgkin Lymphoma, Adult.
The trial portfolio spans Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea
How many clinical trials has Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea sponsored?
ClinicalMetric currently tracks 2 clinical trials sponsored by Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea, of which 2 are actively recruiting participants. These trials cover conditions including Large B Cell Lymphoma, Hodgkin Lymphoma, Adult. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea research focus on?
Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea clinical trials span Large B Cell Lymphoma, Hodgkin Lymphoma, Adult. The research pipeline includes Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea clinical trial?
To participate in a Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea trials with current recruitment status updated daily.
Clinical Trials by Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea
NCT07126236 Phase 2
Recruiting
Response-adaptive to Epcoritamab In First Relapse: Study to Evaluate the Efficacy of Eptoritamab in Patients With Relapse/Refractory Large B Cell Lymphoma
Large B Cell Lymphoma
NCT04378647 Phase 2
Recruiting
BREntuximab Vedotin in SEcond LIne Therapy BEfore Transplant
Hodgkin Lymphoma, Adult
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology